Literature DB >> 11304467

Role of sex differences and effects of endothelial NO synthase deficiency in responses of carotid arteries to serotonin.

K G Lamping1, F M Faraci.   

Abstract

We examined the hypothesis that contraction of the carotid arteries to serotonin is normally inhibited by endothelial NO synthase (eNOS) and is enhanced in mice lacking the gene for eNOS. Because the influence of eNOS may vary with the sex of the mouse, we also tested whether responses to serotonin were dependent on sex. We studied carotid arteries in vitro from littermate control (eNOS(+/+)) mice, heterozygous (eNOS(+/-)) mice, and homozygous eNOS-deficient (eNOS(-/-)) mice (male and female). Contraction to serotonin was greater in male eNOS(+/+) mice than in female eNOS(+/+) mice. In male mice, contraction to serotonin increased by approximately 40% and 2.5-fold in male eNOS(+/-) and eNOS(-/-) mice, respectively. Contraction to serotonin was more than doubled in female eNOS(+/-) mice and increased >5-fold in arteries from eNOS(-/-) mice. In contrast, maximum vasoconstriction to U46619 was similar in male and female eNOS(+/+), eNOS(+/-), and eNOS(-/-) mice. Relaxation to acetylcholine was not different in male and female eNOS(+/+) or eNOS(+/-) mice but was absent in eNOS(-/-) mice. These findings suggest that the contraction of carotid arteries to serotonin is influenced by the sex of the animal. eNOS deficiency in gene-targeted mice is associated with enhanced contraction to serotonin, particularly in female mice, providing direct evidence that eNOS is a major determinant of vascular effects of serotonin. The results with eNOS(+/-) mice suggest a "gene-dosing" effect for vascular responses to serotonin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304467     DOI: 10.1161/01.atv.21.4.523

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  19 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

3.  Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.

Authors:  Robrecht Thoonen; Patrick Y Sips; Kenneth D Bloch; Emmanuel S Buys
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

4.  Vascular phenotype of amyloid precursor protein-deficient mice.

Authors:  Livius V d'Uscio; Zvonimir S Katusic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-22       Impact factor: 4.733

5.  Increased aortic intimal proliferation due to MasR deletion in vitro.

Authors:  Hiba Alsaadon; Peter Kruzliak; Arthur Smardencas; Alan Hayes; Michael Bader; Peter Angus; Chandana Herath; Anthony Zulli
Journal:  Int J Exp Pathol       Date:  2015-02-10       Impact factor: 1.925

6.  Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.

Authors:  Andreas M Beyer; Gary L Baumbach; Carmen M Halabi; Mary L Modrick; Cynthia M Lynch; Thomas D Gerhold; Shams M Ghoneim; Willem J de Lange; Henry L Keen; Yau-Sheng Tsai; Nobuyo Maeda; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2008-02-19       Impact factor: 10.190

7.  The role of rho kinase in sex-dependent vascular dysfunction in type 1 diabetes.

Authors:  Daniel W Nuno; Kathryn G Lamping
Journal:  Exp Diabetes Res       Date:  2010-03-24

8.  Role of CaMKII in Ang-II-dependent small artery remodeling.

Authors:  Anand M Prasad; Pimonrat Ketsawatsomkron; Daniel W Nuno; Olha M Koval; Megan E Dibbern; Ashlee N Venema; Curt D Sigmund; Kathryn G Lamping; Isabella M Grumbach
Journal:  Vascul Pharmacol       Date:  2016-09-20       Impact factor: 5.773

9.  Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.

Authors:  Anand M Prasad; Donald A Morgan; Daniel W Nuno; Pimonrat Ketsawatsomkron; Thomas B Bair; Ashlee N Venema; Megan E Dibbern; William J Kutschke; Robert M Weiss; Kathryn G Lamping; Mark W Chapleau; Curt D Sigmund; Kamal Rahmouni; Isabella M Grumbach
Journal:  J Am Heart Assoc       Date:  2015-06-15       Impact factor: 5.501

10.  5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.

Authors:  Peter M Nelson; Jeremy S Harrod; Kathryn G Lamping
Journal:  Exp Diabetes Res       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.